1
|
Orliaguet M, Brenaut E, Ficheux A, Boisramé S, Misery L. Psychogenic and neurogenic components in patients with psychogenic or neuropathic pruritus: PRURINEURO: A non-interventional single-centre prospective assay. Skin Health Dis 2023; 3:e267. [PMID: 38047259 PMCID: PMC10690707 DOI: 10.1002/ski2.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 05/30/2023] [Accepted: 06/21/2023] [Indexed: 12/05/2023]
Abstract
Background The causes of pruritus are multiple and commonly classified into six different categories: dermatological, systemic, neuropathic, psychogenic, mixed and idiopathic. In clinical practice, psychogenic and neurogenic mechanisms tend to be separated in the etiological diagnosis of neuropathic or psychogenic disorders; nevertheless, studies investigating the respective psychogenic and neurogenic components are lacking. Objective The main objective of this work was to highlight the differences and potential common characteristics between psychogenic pruritus and neuropathic pruritus. Methods This study was a noninterventional single-centre prospective assay. Patients with neuropathic (NP) or psychogenic (PP) pruritus were proposed to participate. The psychogenic and neurogenic components of pruritus in these patients were evaluated using six validated questionnaires or criteria, namely, the diagnosis criteria of psychogenic pruritus, the NP5 questionnaire, the Brest Pruritus Qualitative Assessment Questionnaire, Hospital Anxiety and Depression Scale, Toronto Alexithymia Scale, and DN4i. Results Twenty-five patients with NP and 15 with PP were included. A difference between the two groups was observed for NP5, with mean scores of 2.8 ± 0.9 and 1.4 ± 1 for the NP and PP groups, respectively (p < 0.0001). For depression, the average score was 3.5 ± 3.9 for the NP group and 7.5 ± 5.1 for the PP group (p < 0.02). Conclusion While neuropathic and psychogenic disorders are different diagnoses, neuropathic and psychogenic components may exist simultaneously in patients with NP or PP.
Collapse
Affiliation(s)
- Marie Orliaguet
- LIENUniversity BrestBrestFrance
- Departments of Oral SurgeryBrest University HospitalBrestFrance
| | - Emilie Brenaut
- LIENUniversity BrestBrestFrance
- Departments of DermatologyBrest University HospitalBrestFrance
| | - Anne‐Sophie Ficheux
- LIENUniversity BrestBrestFrance
- Departments of DermatologyBrest University HospitalBrestFrance
| | - Sylvie Boisramé
- Departments of Oral SurgeryBrest University HospitalBrestFrance
| | - Laurent Misery
- LIENUniversity BrestBrestFrance
- Departments of DermatologyBrest University HospitalBrestFrance
| |
Collapse
|
2
|
Orliaguet M, Fong SB, Le Pottier L, Meuric V, Boisramé S, Bonnaure-Mallet M, Pers JO. Tolerance to intraoral biofilms and their effectiveness in improving mouth dryness and modifying oral microbiota in patients with primary Sjögren's syndrome: "Predelfi study". Front Microbiol 2023; 14:1071683. [PMID: 37293235 PMCID: PMC10245914 DOI: 10.3389/fmicb.2023.1071683] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2022] [Accepted: 01/10/2023] [Indexed: 09/29/2023] Open
Abstract
INTRODUCTION Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease characterized by exocrine gland dysfunction. No therapeutic strategy is sufficient on its own for the management of dry mouth and therapeutic innovations are required. METHODS This Predelfi study was a single-center, prospective, comparative, randomized, double-blind, cross-over controlled study with the primary objective of assessing the tolerance to and effectiveness of two adhesive biofilms (containing prebiotics and, sodium alginate, respectively) in patients with pSS and hyposialia (#NCT04206826 in ClinicalTrials.gov). Secondary objectives were to obtain initial data regarding the clinical effectiveness of such biofilms in the improvement of signs and symptoms related to dry mouth and potential changes in the oral microbiota. Ten pSS patients with pSS were included (9 females and 1 male) with a mean age of 58.1 ± 14.0 years. RESULTS AND DISCUSSION Tolerance to the prebiotic and sodium alginate biofilms was assessed by the patients (visual analog scale [VAS] score 66.7 and 87.6, respectively) and the practitioner (90 and 100, respectively). The absolute changes in the VAS scores at the start and end of each treatment period highlighted an improvement in mouth dryness for the sodium alginate versus the prebiotic biofilm. The VAS scores for other parameters (mouth burning sensation; taste alteration; chewing; swallowing and speech difficulties) remained globally comparable between the two groups. Unstimulated salivary flow showed no changes regardless of the biofilm used. Regarding the oral microbiota, the sodium alginate biofilm increased the abundance of the Treponema genus, whereas the use of the prebiotic biofilm as the first treatment increased the abundance of the genera Veillonella and Prevotella. Nevertheless, the prebiotic biofilm appeared to stimulate "milder" genera with regard to periodontal infections. Furthermore, pre-treatment with the prebiotic biofilm prevented the emergence of the Treponema genus induced by subsequent treatment with the sodium alginate biofilm, suggesting a potential protective effect.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Jacques-Olivier Pers
- Univ Brest, CHU de Brest, Brest, France
- LBAI, U1227, Univ Brest, Inserm, Brest, France
| |
Collapse
|
3
|
Hamon B, Orliaguet M, Misery L, Boisramé S. Burning mouth syndrome and pelvodynia: A literature review. Medicine (Baltimore) 2023; 102:e32648. [PMID: 36701734 PMCID: PMC9857247 DOI: 10.1097/md.0000000000032648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Burning mouth syndrome (BMS) and pelvodynia are chronic pain still poorly understood and the links between them are all the more so. Health professionals therefore have few resources to understand, diagnose and treat these pains. They may consider and treat these ailments individually, which does not represent optimal care management for the patient and leads to overmedication. This article aims to highlight their contiguity from epidemiological, etiological, diagnostic, and therapeutic perspectives. This study was based on articles which were found using databases such as PubMed and Web of Science. No exclusion criteria were used. Fourteen studies were reviewed. This present work shows that the clinical presentations of these syndromes are similar, as exemplified by their strong association with anxiety and depression. The neurophysiological mechanisms involved in these conditions are similar to those in patients. The diagnosis is essentially based on visual examination and an elimination of all other possible causes. In addition, this work promotes the fact that a common therapy can be implemented when BMS and pelvodynia co-occur. However, the literature on the subject is still very limited. This can be deepened by exploring all the effective treatments in BMS and vulvodynia for penoscrotodynia. Finally, for all these pains, there is a therapeutic order to respect starting with a psychological approach, then topical treatments, systemic therapy and surgical. This therapeutic gradient assists practitioner in their patient's pain management. This article also allows health care providers to quickly find an effective systemic treatment for a patient with both BMS and pelvodynia.
Collapse
Affiliation(s)
- Bérenger Hamon
- UFR d’Odontologie, University of Western Brittany, Brest, France
- * Correspondence: B. Hamon, UFR d’Odontologie, University of Western Brittany, Brest 29200, France (e-mail: )
| | - Marie Orliaguet
- Centre Hospitalier Régional Universitaire de Brest, Brest, France
- * Correspondence: B. Hamon, UFR d’Odontologie, University of Western Brittany, Brest 29200, France (e-mail: )
| | - Laurent Misery
- Centre Hospitalier Régional Universitaire de Brest, Brest, France
- * Correspondence: B. Hamon, UFR d’Odontologie, University of Western Brittany, Brest 29200, France (e-mail: )
| | - Sylvie Boisramé
- UFR d’Odontologie, University of Western Brittany, Brest, France
- Centre Hospitalier Régional Universitaire de Brest, Brest, France
- * Correspondence: B. Hamon, UFR d’Odontologie, University of Western Brittany, Brest 29200, France (e-mail: )
| |
Collapse
|
4
|
Petagna C, Bocqueho L, Framery C, Ferrec G, Herry H, Misery L, Boisramé S. Interest of periodontal maintenance in improving autoimmune diseases: about an oral lichen planus case report. J Oral Med Oral Surg 2022. [DOI: 10.1051/mbcb/2021046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Introduction: Oral lichen planus is an autoimmune inflammatory disease. These clinical manifestations can sometimes be confused and cumulated with clinical signs of periodontal disorders. The aim of this work is to illustrate the interest of a periodontal follow-up in the management of oral lichen planus by a clinical case report. Observation: A patient came for a consultation in dermatology for a persistent gingival erythema. The diagnosis of oral lichen planus was made and treatments were successively implemented. After six months of follow-up, an inflammatory gum was still present without showing improvement. A stage 3, grade B periodontitis associated with oral lichen planus was diagnosed and a periodontal treatment was initiated, combined with corticosteroids treatment as mouthwash. Four months after the beginning of this treatment, a marked decrease in gingival erythema was observed. Comments: There is often a close relationship between oral lichen planus and periodontal disease therefore a multidisciplinary approach can be very useful for optimal management.
Collapse
|
5
|
Chihaby N, Orliaguet M, Le Pottier L, Pers JO, Boisramé S. Treatment of Sjögren's Syndrome with Mesenchymal Stem Cells: A Systematic Review. Int J Mol Sci 2021; 22:ijms221910474. [PMID: 34638813 PMCID: PMC8508641 DOI: 10.3390/ijms221910474] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2021] [Revised: 09/23/2021] [Accepted: 09/23/2021] [Indexed: 01/10/2023] Open
Abstract
Mesenchymal stem cells (MSCs) are ubiquitous in the human body. Mesenchymal stem cells were initially isolated from bone marrow and later from other organs such as fatty tissues, umbilical cords, and gingiva. Their secretory capacities give them interesting immunomodulatory properties in cell therapy. Some studies have explored the use of MSCs to treat Sjögren’s syndrome (SS), a chronic inflammatory autoimmune disease that mainly affects exocrine glands, including salivary and lacrimal glands, although current treatments are only palliative. This systematic review summarizes the current data about the application of MSCs in SS. Reports show improvements in salivary secretions and a decrease in lymphocytic infiltration in salivary glands in patients and mice with SS after intravenous or infra-peritoneal injections of MSCs. MSC injections led to a decrease in inflammatory cytokines and an increase in anti-inflammatory cytokines. However, the intrinsic mechanism of action of these MSCs currently remains unknown.
Collapse
Affiliation(s)
- Najwa Chihaby
- UFR d’Odontologie, University of Western Brittany, 29200 Brest, France; (N.C.); (M.O.); (L.L.P.); (S.B.)
| | - Marie Orliaguet
- UFR d’Odontologie, University of Western Brittany, 29200 Brest, France; (N.C.); (M.O.); (L.L.P.); (S.B.)
- CHU de Brest, 29609 Brest, France
| | - Laëtitia Le Pottier
- UFR d’Odontologie, University of Western Brittany, 29200 Brest, France; (N.C.); (M.O.); (L.L.P.); (S.B.)
- Inserm, LBAI, University of Western Brittany, UMR1227, 29609 Brest, France
| | - Jacques-Olivier Pers
- UFR d’Odontologie, University of Western Brittany, 29200 Brest, France; (N.C.); (M.O.); (L.L.P.); (S.B.)
- CHU de Brest, 29609 Brest, France
- Inserm, LBAI, University of Western Brittany, UMR1227, 29609 Brest, France
- Correspondence: ; Fax: +33-298223847
| | - Sylvie Boisramé
- UFR d’Odontologie, University of Western Brittany, 29200 Brest, France; (N.C.); (M.O.); (L.L.P.); (S.B.)
- CHU de Brest, 29609 Brest, France
| |
Collapse
|
6
|
Falguière A, LeGruiec C, Herry H, Genest-Beucher S, Dessus JM, Boisramé S. Contribution of virtual reality in oral surgery: A literature review. J Stomatol Oral Maxillofac Surg 2021; 122:405-410. [PMID: 33610770 DOI: 10.1016/j.jormas.2021.02.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2020] [Revised: 01/14/2021] [Accepted: 02/11/2021] [Indexed: 10/22/2022]
Abstract
Oral cavity care is very much associated with perceptions of pain and anxiety. Oral health practitioners have many solutions in order to reduce patients' apprehension, and an alternative non-drug technique has increased: the use of virtual reality (VR). The aim of this review is to highlight the contribution of virtual reality headsets in reducing anxiety and pre- and post- operative pain in patients having oral surgery. PubMed and Cochrane Library have been searched for scientific articles with MESH words «virtual reality », « oral surgery », « anxiety » and « pain ». 8 articles were identified and 6 met the inclusion criteria. Among the 6 articles analyzed, 4 were control trials and 2 were methodological descriptions. 2 clinical trials found statistically significant results on the outcome measures of pre-operative and post-operative anxiety and pain felt. The use of VR in oral surgery seems to have an impact in reducing anxiety and pre- and post- operative pain, but more studies are needed to confirm its effectiveness.
Collapse
Affiliation(s)
- Arthur Falguière
- Resident in Oral Surgery Department, University Hospital of Brest, France.
| | - Clara LeGruiec
- Oral Surgery Department, University Hospital of Brest, France
| | - Héloïse Herry
- Oral Surgery Department, University Hospital of Brest, France
| | | | - Jean-Michel Dessus
- Head of Department, Dental Surgery, French Army Hospital of Brest, France
| | - Sylvie Boisramé
- University Professor-Hospital Praticioner in Oral Surgery Department, Sense Organs Pole Leader, Brest, France
| |
Collapse
|
7
|
Orliaguet M, Boisramé S, Eveillard J, Pan‐Petesch B, Couturier M, Rebière V, Guillerm G, Le Bousse‐Kerdiles M, Misery L, Lippert E, Ianotto J. Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms. eJHaem 2020; 1:350-352. [PMID: 35847694 PMCID: PMC9176112 DOI: 10.1002/jha2.15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Accepted: 05/01/2020] [Indexed: 11/10/2022]
Affiliation(s)
| | | | - Jean‐Richard Eveillard
- Service d'Hématologie Clinique, Institut de Cancéro‐HématologieCHRU de Brest Brest France
| | - Brigitte Pan‐Petesch
- Service d'Hématologie Clinique, Institut de Cancéro‐HématologieCHRU de Brest Brest France
- EA3878, Groupe d'Etude des Thromboses de Bretagne Occidentale, GETBOCHRU de Brest Brest France
| | - Marie‐Anne Couturier
- Service d'Hématologie Clinique, Institut de Cancéro‐HématologieCHRU de Brest Brest France
| | - Vincent Rebière
- Service d'Hématologie Clinique, Institut de Cancéro‐HématologieCHRU de Brest Brest France
| | - Gaelle Guillerm
- Service d'Hématologie Clinique, Institut de Cancéro‐HématologieCHRU de Brest Brest France
| | | | | | - Eric Lippert
- France Intergroupe des Néoplasies Myéloprolifératives (FIM)
- Laboratoire d'HématologieCHRU de Brest Brest France
- INSERM, UMR 1078Université de Brest Brest France
| | - Jean‐Christophe Ianotto
- Service d'Hématologie Clinique, Institut de Cancéro‐HématologieCHRU de Brest Brest France
- EA3878, Groupe d'Etude des Thromboses de Bretagne Occidentale, GETBOCHRU de Brest Brest France
- France Intergroupe des Néoplasies Myéloprolifératives (FIM)
| |
Collapse
|
8
|
Marteau P, Cornec D, Gouillou M, Jousse-Joulin S, Guellec D, Costa S, Marhadour T, Carvajal Alegria G, Varache S, Gauvin Y, Boisramé S, Le Pottier L, Renaudineau Y, Pers JO, Saraux A, Devauchelle-Pensec V. Assessment of major salivary gland size in primary Sjögren's syndrome: Comparison between clinical examination and ultrasonography. Joint Bone Spine 2019; 86:627-632. [DOI: 10.1016/j.jbspin.2019.01.025] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2018] [Revised: 01/16/2019] [Accepted: 01/30/2019] [Indexed: 11/29/2022]
|
9
|
Kaboré WAD, Dembélé R, Bagré TS, Konaté A, Boisramé S, Chevalier V, Konsem T, Traoré AS, Barro N. Characterization and Antimicrobial Susceptibility of Lactococcus lactis Isolated from Endodontic Infections in Ouagadougou, Burkina Faso. Dent J (Basel) 2018; 6:dj6040069. [PMID: 30544668 PMCID: PMC6313549 DOI: 10.3390/dj6040069] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2018] [Revised: 12/02/2018] [Accepted: 12/05/2018] [Indexed: 12/16/2022] Open
Abstract
Background: This study aimed to characterize and test the antimicrobial susceptibility of Lactococcus lactis isolated in endodontic infections in Burkina Faso. Material and methods: This was a prospective study conducted at the Municipal Oral Health Center of Ouagadougou, Burkina Faso, from June to October 2014. Clinical data were collected using a questionnaire form. The method of streaking on selective medium was used to isolate bacteria. Identification was made using the API 20 Strep gallery. Antibiotic susceptibility was performed by the diffusion method on solid medium. Results: One hundred and twenty-five (125) patients were received with a significant proportion from the age group of 19 to 40 years (55.2%). Apical periodontitis accounted for 50.4% and cellulitis for 49.6% of cases. Lactococcus lactis ssp. lactis was identified in five exudate samples. Isolates were 100% resistant to cefixime and metronidazole, 80% to ceftriaxone, cefuroxime, cefotaxime, chloramphenicol and 60% to penicillin G, amoxicillin, amoxicillin clavulanic acid. A multidrug resistance of more than three families of antibiotics was noticed. No strains produced extended spectrum ß-lactamases. Conclusion: Lactococcus lactis is part of endodontic biofilm. The reported strong antibiotic resistance involving endodontic therapy will focus on the effect of the disinfectant solution and the mechanical action of the canal instruments.
Collapse
Affiliation(s)
- Wendpoulomdé Aimé Désiré Kaboré
- Laboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food (LaBESTA)/Center for Research in Biological, Food and Nutritional Sciences (CRSBAN)/Graduate School of Science and Technology (EDST), University of Ouaga I, Professor Joseph KI-ZERBO, Ouagadougou 03 BP 7021, Burkina Faso.
- Training and Research Unit in Health Sciences (UFR/SDS), University of Ouaga I, Professor Joseph KI-ZERBO, Ouagadougou 03 BP 7021, Burkina Faso.
| | - René Dembélé
- Laboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food (LaBESTA)/Center for Research in Biological, Food and Nutritional Sciences (CRSBAN)/Graduate School of Science and Technology (EDST), University of Ouaga I, Professor Joseph KI-ZERBO, Ouagadougou 03 BP 7021, Burkina Faso.
| | - Touwendsida Serge Bagré
- Laboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food (LaBESTA)/Center for Research in Biological, Food and Nutritional Sciences (CRSBAN)/Graduate School of Science and Technology (EDST), University of Ouaga I, Professor Joseph KI-ZERBO, Ouagadougou 03 BP 7021, Burkina Faso.
| | - Ali Konaté
- Laboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food (LaBESTA)/Center for Research in Biological, Food and Nutritional Sciences (CRSBAN)/Graduate School of Science and Technology (EDST), University of Ouaga I, Professor Joseph KI-ZERBO, Ouagadougou 03 BP 7021, Burkina Faso.
| | - Sylvie Boisramé
- University Laboratory of Biodiversity and Microbial Ecology, EA 3882/University of Western Brittany, 22 av C. Desmoulins 29238 Brest CEDEX, France.
| | - Valérie Chevalier
- Department of Odontology Conservative and Endodontics, University of Western Brittany, 22 av C. Desmoulins 29238 Brest CEDEX, France.
| | - Tarcissus Konsem
- Training and Research Unit in Health Sciences (UFR/SDS), University of Ouaga I, Professor Joseph KI-ZERBO, Ouagadougou 03 BP 7021, Burkina Faso.
| | - Alfred S Traoré
- Laboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food (LaBESTA)/Center for Research in Biological, Food and Nutritional Sciences (CRSBAN)/Graduate School of Science and Technology (EDST), University of Ouaga I, Professor Joseph KI-ZERBO, Ouagadougou 03 BP 7021, Burkina Faso.
| | - Nicolas Barro
- Laboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food (LaBESTA)/Center for Research in Biological, Food and Nutritional Sciences (CRSBAN)/Graduate School of Science and Technology (EDST), University of Ouaga I, Professor Joseph KI-ZERBO, Ouagadougou 03 BP 7021, Burkina Faso.
| |
Collapse
|
10
|
Fangous MS, Lazzouni I, Alexandre Y, Gouriou S, Boisramé S, Vallet S, Le Bihan J, Ramel S, Héry-Arnaud G, Le Berre R. Prevalence and dynamics of Lactobacillus sp. in the lower respiratory tract of patients with cystic fibrosis. Res Microbiol 2018; 169:222-226. [PMID: 29800681 DOI: 10.1016/j.resmic.2018.03.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2017] [Revised: 03/16/2018] [Accepted: 03/16/2018] [Indexed: 12/22/2022]
Abstract
No prevalence or dynamics analysis of Lactobacilli in the lung of cystic fibrosis (CF) patients has yet been conducted. In order to use them as probiotics in the treatment of Pseudomonas aeruginosa infection, we describe their lung epidemiology. Over a period of 8 months, we analyzed 279 sputum samples from 124 CF patients classified according to their P. aeruginosa Leeds status of colonization. A total of 137 strains belonging to 11 species were isolated. The prevalence of carriage was 61%. No difference in species diversity or frequency was observed according to Leeds criteria. The next step will be to focus on the strain level.
Collapse
Affiliation(s)
- Marie-Sarah Fangous
- Département de Bactériologie-Virologie-Hygiène hospitalière et Parasitologie Mycologie, CHRU La Cavale Blanche, Brest, France; Inserm UMR 1078, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France.
| | - Ismaïl Lazzouni
- Département de Bactériologie-Virologie-Hygiène hospitalière et Parasitologie Mycologie, CHRU La Cavale Blanche, Brest, France.
| | - Youenn Alexandre
- Inserm UMR 1078, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France.
| | - Stéphanie Gouriou
- Inserm UMR 1078, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France.
| | - Sylvie Boisramé
- Inserm UMR 1078, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France; Département d'odontologie, CHRU Morvan, Brest, France.
| | - Sophie Vallet
- Département de Bactériologie-Virologie-Hygiène hospitalière et Parasitologie Mycologie, CHRU La Cavale Blanche, Brest, France; Inserm UMR 1078, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France.
| | - Jean Le Bihan
- Centre de Ressource et de Compétence de la Mucoviscidose, Fondation Ildys, Presqu'île de Perharidy, 29680, Roscoff, France.
| | - Sophie Ramel
- Centre de Ressource et de Compétence de la Mucoviscidose, Fondation Ildys, Presqu'île de Perharidy, 29680, Roscoff, France.
| | - Geneviève Héry-Arnaud
- Département de Bactériologie-Virologie-Hygiène hospitalière et Parasitologie Mycologie, CHRU La Cavale Blanche, Brest, France; Inserm UMR 1078, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France.
| | - Rozenn Le Berre
- Inserm UMR 1078, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France; Département de Médecine Interne et Pneumologie, CHRU La Cavale Blanche, Brest, France.
| |
Collapse
|
11
|
Demoersman J, Pochard P, Framery C, Simon Q, Boisramé S, Soueidan A, Pers JO. B cell subset distribution is altered in patients with severe periodontitis. PLoS One 2018; 13:e0192986. [PMID: 29447240 PMCID: PMC5814041 DOI: 10.1371/journal.pone.0192986] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2017] [Accepted: 02/01/2018] [Indexed: 01/10/2023] Open
Abstract
Several studies have recently highlighted the implication of B cells in physiopathogenesis of periodontal disease by showing that a B cell deficiency leads to improved periodontal parameters. However, the detailed profiles of circulating B cell subsets have not yet been investigated in patients with severe periodontitis (SP). We hypothesised that an abnormal distribution of B cell subsets could be detected in the blood of patients with severe periodontal lesions, as already reported for patients with chronic inflammatory diseases as systemic autoimmune diseases. Fifteen subjects with SP and 13 subjects without periodontitis, according to the definition proposed by the CDC periodontal disease surveillance work group, were enrolled in this pilot observational study. Two flow cytometry panels were designed to analyse the circulating B and B1 cell subset distribution in association with the RANKL expression. A significantly higher percentage of CD27+ memory B cells was observed in patients with SP. Among these CD27+ B cells, the proportion of the switched memory subset was significantly higher. At the same time, human B1 cells, which were previously associated with a regulatory function (CD20+CD69-CD43+CD27+CD11b+), decreased in SP patients. The RANKL expression increased in every B cell subset from the SP patients and was significantly greater in activated B cells than in the subjects without periodontitis. These preliminary results demonstrate the altered distribution of B cells in the context of severe periodontitis. Further investigations with a larger cohort of patients can elucidate if the analysis of the B cell compartment distribution can reflect the periodontal disease activity and be a reliable marker for its prognosis (clinical trial registration number: NCT02833285, B cell functions in periodontitis).
Collapse
Affiliation(s)
- Julien Demoersman
- UMR1227, Université de Brest, Inserm, Brest, France
- LabEx IGO, Brest, France
| | - Pierre Pochard
- UMR1227, Université de Brest, Inserm, Brest, France
- LabEx IGO, Brest, France
| | | | - Quentin Simon
- UMR1227, Université de Brest, Inserm, Brest, France
- LabEx IGO, Brest, France
| | | | - Assem Soueidan
- Department of Periodontology, CHU de Nantes, Nantes, France
- Rmes Inserm U1229/UIC11, Université de Nantes, Nantes, France
| | - Jacques-Olivier Pers
- UMR1227, Université de Brest, Inserm, Brest, France
- LabEx IGO, Brest, France
- Service d’odontologie, CHU Brest, Brest, France
- * E-mail:
| |
Collapse
|
12
|
Buron C, Boisramé S, De Moreuil C, Le Duc-Pennec A, Le Berre R. An unpublished case of focal infection on a vascular endoprosthesis graft. J Oral Med Oral Surg 2018. [DOI: 10.1051/mbcb/2017026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Observation: A patient with a prosthetic superior vena cava graft had complications of thrombosis and infection. The blood cultures were positive for Peptostreptococcus micros and Prevotella denticola. The latter are known to exist in oral cavities. Clinical and radiological examinations of the oral cavity revealed the presence of oral infectious foci. Commentary: Superior vena cava prosthetic graft infections of oral origin have not previously been described in the literature. The highlighting of oral infectious foci, their eradication, and the follow-up of patients who had been subject to a vascular graft procedures are essential elements in preventing any associated lesions.
Collapse
|
13
|
Schmouchkovitch A, Remaud M, Simon H, Herry H, Le Toux G, Boisramé S. [Focus: Drug-related osteonecrosis of the jaw]. Presse Med 2017; 47:19-33. [PMID: 29275972 DOI: 10.1016/j.lpm.2017.10.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/31/2017] [Revised: 10/02/2017] [Accepted: 10/04/2017] [Indexed: 11/25/2022] Open
Abstract
Antiresorptives and antiangiogenics are treatments that have proven effective in oncology and the treatment of osteoporosis and they are increasingly prescribed. The care of these patients requires collaboration between the prescriber and the oral health professional to establish an optimized treatment plan. Therapeutic education of the patient is essential for him to understand the issues of good oral health and the adverse effects that can be caused by these treatments. The management is essentially based on the individual benefit/risk balance resulting from the general, local and inherent of the molecule risk factors. Management of drug-related osteonecrosis of the jaw should be as early as possible.
Collapse
Affiliation(s)
| | - Matthieu Remaud
- CHRU de Brest, médecine bucco-dentaire, département d'odontologie, 29200 Brest, France
| | - Hélène Simon
- CHRU de Brest, département d'oncologie, 29200 Brest, France
| | - Héloïse Herry
- CHRU de Brest, hospitalo-universitaire, département de chirurgie orale, 29200 Brest, France
| | - Guy Le Toux
- CHRU de Brest, département de chirurgie orale, 29200 Brest, France
| | - Sylvie Boisramé
- CHRU de Brest, département de chirurgie orale, 29200 Brest, France
| |
Collapse
|
14
|
Abstract
BACKGROUND The purpose of pharmacovigilance (drug safety) is collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. It is meant to identify, characterize, prevent, or minimize actual or potential risks relating to medicinal products. To prevent these adverse effects and improve our practice, health professionals have a duty to report side effects to assess this risk and evaluate the benefit/risk requirements. Mitotane (Lysodren) is used for treating adrenocortical carcinoma. Currently, no side effects concerning oral and genital mucosa have been reported. CASE SUMMARY This case report is about a 50 years old woman. Six months after the initiation on mitotane treatment, she developed erosive lesions located on the oral and vaginal mucosa. These drug reactions were diagnosed as erosive lichen planus by the biopsy. This lichenoid lesions were resistant to the usual treatments, mitotane being at the time not replaceable. CONCLUSION This case describes an unreported adverse effect of mitotane, it is - to our knowledge - the 1st description of erosive lichenoid drug reaction due to Mitotane.
Collapse
Affiliation(s)
| | | | | | | | | | - Guy Le Toux
- Department of Oral Surgery, Brest University Hospital, Brest, France
| | - Sylvie Boisramé
- Department of Oral Surgery, Brest University Hospital, Brest, France
| |
Collapse
|
15
|
Le Gall M, Cornec D, Pers JO, Saraux A, Jousse-Joulin S, Cochener B, Roguedas-Contios AM, Devauchelle-Pensec V, Boisramé S. A prospective evaluation of dental and periodontal status in patients with suspected Sjögren's syndrome. Joint Bone Spine 2016; 83:235-6. [DOI: 10.1016/j.jbspin.2015.02.015] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2014] [Accepted: 02/17/2015] [Indexed: 10/23/2022]
|
16
|
Fénelon M, Catros S, Boisramé S, D’incau E, Tréguer A, Gobel Y, Valette G, Fricain JC. Complications maxillo-faciales associées à la pycnodysostose : présentation de deux cas cliniques et revue de la littérature. ACTA ACUST UNITED AC 2015. [DOI: 10.1051/mbcb/2015032] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
17
|
Hascoet E, Vaillant PY, Tempescul A, Darbin C, Lansonneur C, Boisramé S. Tori et exostoses multiples : présentation d’un cas et revue de la littérature. ACTA ACUST UNITED AC 2015. [DOI: 10.1051/mbcb/2015003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
18
|
Rivas Caldas R, Boisramé S. Upper aero-digestive contamination by Pseudomonas aeruginosa and implications in Cystic Fibrosis. J Cyst Fibros 2014; 14:6-15. [PMID: 24933711 DOI: 10.1016/j.jcf.2014.04.008] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2013] [Revised: 04/25/2014] [Accepted: 04/29/2014] [Indexed: 01/05/2023]
Abstract
BACKGROUND Cystic Fibrosis (CF) is a severe genetic disorder that is common among the Caucasian population. Bacterial respiratory infections are the main cause of morbidity and mortality in CF patients. Pseudomonas aeruginosa is the main pathogen of lower airways (LAW) decline. METHOD To understand chronic broncho-pulmonary colonization, a systematic review is conducted. The aim of our article is to identify the pathways of contamination in the upper aero-digestive tract. RESULTS A large number of articles report that P. aeruginosa is established first at nasopharyngeal sites. The vast majority of authors agree that the upper aero-digestive tract is the first location of colonization by P. aeruginosa and its presence appears to be predictive of subsequent broncho-pulmonary colonization. CONCLUSION This review supports the possible involvement of the nasal and paranasal sinuses and oral cavity as means of contamination.
Collapse
Affiliation(s)
- R Rivas Caldas
- Laboratoire Universitaire de Biodiversité et d'Ecologie Microbienne (LUBEM-EA 3882), Université de Bretagne Occidentale, Université Européenne de Bretagne (UBO-UEB), 22 avenue C. Desmoulins, 29238 Brest Cedex, France.
| | - S Boisramé
- Département de Chirurgie Orale, Pôle Organes des Sens, Centre Hospitalier Régional Universitaire (CHRU), 5 Av. Foch, 29609 Brest Cedex, France; Laboratoire Universitaire de Biodiversité et d'Ecologie Microbienne (LUBEM-EA 3882), (UBO-UEB), 22 avenue C. Desmoulins, 29238 Brest Cedex, France; CRCM, centre de Perharidy, Route de Perharidy, 29680 Roscoff, France.
| |
Collapse
|
19
|
Tempescul A, Querellou S, Ianotto JC, Boisramé S, Valette G, Berthou C. 18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract. Ann Hematol 2009; 89:635-7. [PMID: 19844711 DOI: 10.1007/s00277-009-0842-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2009] [Accepted: 09/21/2009] [Indexed: 11/25/2022]
|